What is Decodex?

DECODEX is a comprehensive research and development project titled “Development of innovative materials for personalized cell therapies and regenerative medicine.”

Led by SC Decode Health SRL, the project aims to revolutionize cancer treatment and regenerative medicine through interdisciplinary collaboration between biomaterial researchers, immunologists, and clinicians.

Here are the specific details of the project:

Project Overview & Timeline

• Project Code: SMIS 336873

• Funding Source: Smart Growth, Digitalization and Financial Instruments Programme 2021–2027 (PoCIDIF).

• Contracting Authority: National Authority for Research (ANC), via the Intermediate Body for Research.

• Duration: 36 months.

• Start Date: November 11, 2025.

• Completion Date: November 11, 2028.

The Consortium

The project is implemented by a partnership consisting of:

1. SC Decode Health SRL (Consortium Leader)

2. "Pius Brînzeu" County Emergency Clinical Hospital Timișoara, OncoGen Centre for Gene and Cellular Therapies (Partner – Public Research Organization)

3. LMS Plastic Surgery Clinique SRL Bucharest (Partner – SME)

4. "Sf. Nectarie" Oncology Centre SRL Craiova (Partner – SME)

Objectives

• General Objective: To promote the development of biomaterials that optimize the function of immune cells used in cancer treatment, anti-aging processes, and regenerative medicine.

• Specific Objectives:

  • Integration of advanced genetic modification techniques for T-lymphocytes to develop personalized CAR-T therapies. This allows treatments to be adapted to the unique genetic characteristics of each oncological case.

  • Establishment of an immune cell bank, providing patients access to personalized autologous cell therapies.

Key Expected Results

The DECODEX project anticipates the following outcomes:

• Regulatory & Software: Development of standard operating procedures, obtaining compliance certificates for biomaterials (CE marking), and creating integrated data management software.

• Research & Development: Acquisition of equipment and consumables for industrial research/experimental development, creation of standardized protocols, and publication of scientific articles.

• Infrastructure: Equipping a facility (hall) with machinery, equipment, and humanoid robots.

• Authorization: Obtaining GMP (Good Manufacturing Practice) authorization for immune cell production and authorization for the cell bank.

• Service Launch: Developing a service for the harvesting, isolation, and long-term storage of immune cells from adults aged 18 to 65.

Why now?

The Reality of Aging: Aging is genetically determined but profoundly shaped by your immune system. While we cannot yet "conserve" young organs, we can now conserve young immune cells.

• The Problem: Traditional cell collection (Apheresis) is stressful, takes 6–8 hours, costs over €16,000, and is often done too late—after conventional therapies fail.

• The Decode Health Solution: We offer "Youth Immune Cell Banking." By collecting your cells while you are healthy, you secure a resource for future treatments (CAR-T, regenerative medicine) at a fraction of the cost.

Stay Informed

Get the latest updates on oncology research